Australia Equine Healthcare Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type (Pharmaceuticals, Vaccines, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software And Services, Others) By Dosage Form (Injectables, Oral Solutions, Tablets, Others) By Application (Inflammatory Diseases, Infectious Diseases, Asthma, Parasitic Infections, Others), By End User (Companion Animal Clinics, Veterinary Hospitals, and Others) and Country Forecast 2020-2031

Australia Equine Healthcare Market was valued at US$ XX in 2024 and grew at XX % CAGR over the historical years (2020 - 2024). The Australian Equine Healthcare Market is projected to reach US$ XX million by 2031 at a CAGR of XX %. The market refers to the business engaged in designing, distributing, and providing medical products and services that are directed at maintaining and improving the health of horses.

The market is driven by a growing rate of equine diseases such as influenza, herpes virus, and West Nile virus, which has increased the demand for preventatives, diagnostics, and therapies. Growing awareness of animal health, advancements in veterinary science, and the application of technologies like AI for lameness diagnosis are also driving the market. But the market is also bound by high-cost advanced treatments, the limited presence of specialized equine care in rural areas, and a relatively small target population when compared to other veterinary markets, which can limit economies of scale and investment in innovation.

Facts & Figures:

• Colic is a relatively common disorder of the equine digestive system. The term colic is used to describe a symptom of abdominal pain, which in horses is usually caused by problems in the gastrointestinal tract.
• Horses that are still growing need 12 to 18 percent of crude protein in their diets, while mature horses only need 8 to 12 percent.
• Horses under the age of five, or those fed grain, need a dental check at least once every 3-6 months.
• Atypical myopathy (also known as 'sycamore poisoning') is a severe and potentially fatal muscle disorder of horses caused by eating sycamore ‘helicopter’ seeds and, to a lesser extent sycamore leaves, that fall onto pasture in the autumn & winter or sycamore seedlings which grow in the Spring.

Key Developments:

• In May 2025, Zoetis expanded its equine vaccine portfolio in Australia by launching a new combination vaccine targeting equine influenza and herpesvirus, aimed at improving compliance and reducing administration time.
• In April 2025, Boehringer Ingelheim partnered with a leading Australian equine research institute to co-develop regenerative therapies for musculoskeletal disorders, focusing on stem cell and PRP-based treatments.
• In March 2025, IDEXX Laboratories introduced a portable diagnostic device tailored for equine clinics in regional Australia, enabling rapid on-site testing for infectious diseases like strangles and West Nile virus.
• In February 2025, Dechra Veterinary Products launched a new line of equine nutritional supplements in Australia, targeting performance horses and aging equines with joint and metabolic support formulas.

Australia Equine Healthcare Market Segmentation:

Based on the product type:

• Pharmaceuticals
• Vaccines
• Medicinal Feed Additives
• Orthobiologics
• Diagnostics
• Software and Services
• Others

Focusing on the pharmaceuticals segment, it is the largest revenue-contributing segment in the market. It includes anti-infectives, anti-inflammatories, antiparasitics, and analgesics prescribed to treat diverse equine afflictions from respiratory infections, musculoskeletal conditions, to gastrointestinal infections. The market is fueled by the high rate of infectious and inflammatory diseases, especially among performance and racehorses. Also, growing emphasis on long-term care and early intervention is driving equine owners and veterinarians towards adopting pharmaceutical regimens specifically targeting specific equine needs. With growing R&D spending and introduction of combination therapies and long-acting products, the segment for pharmaceuticals will continue to lead until 2030.

Based on the dosage form:

• Injectables
• Oral Solutions
• Tablets
• Others

Pertaining to injectables, this dosage form commands a large market share in the market because of its quick onset of action and high rate of bioavailability, thus being best suited for cure of acute ailments like colic, infections, and musculoskeletal trauma. Injectables are commonly used by veterinarians for the administration of vaccines, anti-inflammatories, and antibiotics, particularly in performance and racehorses where quick action is the key. The segment is also gaining from evolving long-acting formulations and release technologies, which lower the rate of administration and enhance compliance. As horse owners more and more place value on efficient and effective treatment protocols, demand for injectable solutions will continue strong through 2030.

Based on the application:

• Inflammatory Diseases
• Infectious Diseases
• Asthma
• Parasitic Infections
• Others

Directed at infectious diseases, this application segment is of utmost significance in the market due to the prevalence and disease burden of such diseases as equine influenza, herpesvirus, strangles, and West Nile virus. The diseases are highly transmissible among horse populations, especially in racing and breeding communities, with resultant increased demand for vaccines, diagnostics, and biosecurity measures. The segment is further supported by government-led vaccination campaigns and increasing consciousness among horse owners about early detection and containment. Expansion in horse mobility for sport and trade has driven the necessity for efficient infectious disease control, which will drive steady investment and innovation in the segment through 2030.

Based on the end user:

• Companion Animal Clinics
• Veterinary Hospitals
• Others

For the veterinary hospitals, this end-user category is one major pusher of the market due to its capability to deliver holistic, high-quality treatment. The centers are typically well-equipped with modern diagnosis equipment, operating theaters, and specialized staff and thus become the go-to centers for the treatment of complex equine conditions such as musculoskeletal disorders, respiratory diseases, and infections. Veterinary clinics are also referral venues for small clinics, especially in cases that require imaging, orthobiologics, or intensive care. The ability to offer preventive and therapeutic care makes them leaders as drivers of new technologies in equine health in Australia.